About this trial
This study aims to evaluate the predictive value of preoperative indocyanine green (ICG) lymphography and high-frequency ultrasound in determining the outcomes of lymphaticovenous anastomosis (LVA) in patients with post-mastectomy upper limb lymphedema. Patients undergoing LVA surgery will undergo preoperative assessment using ICG lymphography and ultrasound mapping of lymphatic vessels and recipient veins. Surgical outcomes will be assessed clinically and functionally through limb circumference measurements, symptom improvement, and postoperative imaging findings. The study seeks to identify imaging predictors associated with successful LVA outcomes and improved postoperative recovery.
Eligibility criteria
Qualifiers
• Female patients aged 18 to 75 years.
Unilateral secondary upper limb lymphedema following mastectomy with axillary lymph node dissection.
Minimum interval of six months from completion of oncological treatment (surgery, radiotherapy, systemic therapy) to enrollment.
ISL clinical stage I or II at the time of enrollment; late stage II eligible if patent lymphatic vessels are identified on preoperative HFUS.
Disqualifiers
Bilateral upper limb lymphedema.
Active locoregional or distant oncological recurrence.
Prior lymphatic surgery on the affected limb.
Severe peripheral vascular disease.
Trial design
Treatments tested in this trial
- lymphatic-venous anastamosis
Treatment groups
Locations
1Sponsors and collaborators
Assiut University
Lead sponsor